SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Life sciences intellectual property licensing at the Massachusetts Institute of Technology · Study

ReviewLife sciences intellectual property licensing at the Massachusetts Institute of Technology

Samuel T. Huang2021

Review2021

Life sciences intellectual property licensing at the Massachusetts Institute of Technology

Samuel T. Huang · Kien Wei Siah · Detelina Vasileva · Shirley Chen · Lita L. Nelsen · Andrew W. Lo

16 citations·0/0 files stored·Nature Biotechnology

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Intellectual Property and Patents Pharmaceutical Economics and Policy Biotechnology and Related Fields

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 16 citations exist upstream.

References

2009Lessons from 60 years of pharmaceutical innovation 2011The Role of Public-Sector Research in the Discovery of Drugs and Vaccines 2013An Improved Approach To Measuring Drug Innovation Finds Steady Rates Of First-In-Class Pharmaceuticals, 1987–2011 20172016 FDA drug approvals 2005Macro trends in pharmaceutical innovation 2004Inside the Triple Helix: Technology Transfer And Commercialization In The Life Sciences

Cited by

2022Systematic analysis of 50 years of Stanford University technology transfer and commercialization 2023Who counts as an inventor? Seniority and gender in 430,000 biomedical inventor–researcher teams

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2011US academic drug discoveryother · 2 shared references 2011How to Revive Breakthrough Innovation in the Pharmaceutical Industryarticle · 2 shared references 2019Public sector financial support for late stage discovery of new drugs in the United States: cohort studyarticle · 2 shared references 2016Public- and Private-Sector Contributions to the Research and Development of the Most Transformational Drugs in the Past 25 Years: From Theory to Therapyarticle · 2 shared references 2023Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019article · 2 shared references 2012Translational research: the changing landscape of drug discoveryreview · 2 shared references

Details

Year2021

Typereview

Published2021-03-01

VenueNature Biotechnology

ISSN-L0733-222X

Languageen

Citations16

Files0 public / 0

ShelfIntellectual Property and Patents

Identifiers

doi10.1038/s41587-021-00843-5

openalex_workW3133614619

Links

Imported from OpenAlex (CC0) — nothing here is generated.